Skip to main content

2016 is required

Our microwave tech lands in the Middle East

the UK, US, Canada, Australia, and New Zealand and has been used in almost 200,000 treatments since it was launched in 2016. Elie Helou, Swift® partner for the Middle East said: "I am thrilled to be working in partnership with Emblation to introduce...

Major Singapore deal sets out route for global expansion

equipment distributors in Singapore to expand the global reach of our innovative microwave device. Since launching Swift® in 2016 for the treatment of stubborn skin lesions we have secured distribution agreements across 24 different countries, with...

Emblation launches major $2m US clinical trial

two scientists who met while studying at Heriot Watt University in Edinburgh. Swift® was launched to the podiatry market in 2016 and quickly made an impression with clinicians. The firm’s growth was boosted in 2021, when it was backed by London-based...

Emblation - the company behind Swift

range of treatments. Working closely with leading Podiatry and Dermatology specialists, the pair went on to launch Swift® in 2016, as a radical new treatment in the podiatry sector. Emblation's cutting-edge microwave technology is transforming the...

Emblation Shortlisted for Best New Product Award

products or services have had on the market that they operate within. Emblation was named "Innovator of the Year" at the 2016 awards ceremony and have been nominated for this year's "Best New Product" award for Swift - the pioneering new microwave...

Emblation featured in Leading Microwave Magazine

Microwave have been featured in the 'Microwave Energy: Making Medical Advances' issue of Microwaves & RF, released November 2016. The article titled 'Microwave Energy Aims to Improve health' highlights how microwave technology has made a substantial...

Scottish health tech innovator hits 100,000 treatments in UK

now trained in its use. Gary Beale, our CEO, said: "When we launched our Swift device into UK clinics from September 2016, we promised to bring benefits to the entire podiatry community where there had been little investment or innovation. We believe we...

Crossover breakthrough into an aesthetic clinic

and CEO said: "We have dramatically changed the landscape for podiatrists and for verrucae patients since launching in 2016. With our first venture into dermal and aesthetic clinics we hope to deliver similar, seismic improvement for patients with a...

Microwave technology for verrucae is a sound investment

exceptional investment that benefits patients and brings huge advancement to our clinic." Anna purchased the Swift device in 2016 and had recouped that investment in just three months. The clinic offers a minimum three treatment package, costing the...

Microwave health tech firm uses war chest to conquer Europe

50% and ongoing fit out of our new HQ in Stirling. Since launching a radical new treatment device for the podiatry sector in 2016, we have enjoyed major success with thousands of practitioners using our microwave technology across the UK, US, Canada and...

Celebrating 200,000 treatments

of that innovation. "It's telling that we have reached this milestone despite the fact that Swift® was only launched in 2016. We are still very much in start-up mode, so to have achieved these levels in a mature market with an entirely new treatment is...

Emblation CEO wins prestigious life sciences honour

us.” Emblation was established by Gary Beale and Eamon McErlean, who met during their postgraduate studies in Edinburgh. In 2016, they made an innovative contribution to the podiatry sector by launching Swift®, which has gone from strength to strength...

Leading podiatrist hails Swift as most effective treatment

and Eamon McErlean, who met during post-graduate studies at Heriot Watt university. The pair went on to launch Swift® in 2016, as a radical new treatment in the podiatry & dermatology sectors. Gary Beale, co-founder, and CEO said: “We continue to show...

Clinical trials to crack embarrassing nail disease

Emblation was established by Gary Beale and Eamon McErlean, who met during their postgraduate studies in Edinburgh. In 2016, they made an innovative contribution to the podiatry sector by launching Swift®, which has gone from strength to strength since....

Council leaders welcome Emblation at new Stirling office

and Eamon McErlean, who met during post-graduate studies at Heriot Watt university. The pair went on to launch Swift® in 2016, as a radical new treatment in the podiatry & dermatology sectors. Share on social social social social Get in touch +44...

Microwave Tech Saves Man From Double Leg Amputation

treatment and hope that in the future more people can benefit from this technology.” Our Swift technology was developed in 2016 by scientists Gary Beale and Eamon McErlean who met while studying at Edinburgh’s Heriot-Watt University and went on to...

Customer experiences

Anna Cooper Hall Farnham Foot Clinic, UK Anna was an early adopter of Swift when it launched in the UK in 2016. She recouped her investment in just 3 months. She was so impressed by the many positive outcomes she experienced with Swift, she went on to...